
|Articles|February 1, 2020
- Pharmaceutical Executive-02-01-2020
- Volume 40
- Issue 2
Pharmaceutical Executive, February 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Improving the Link from Lab to Physicianabout 6 years ago
Engaging the New HCP in the Digital Worldabout 6 years ago
Jay Galeota: A Better Way to Pharmaabout 6 years ago
Surfacing Insights: AI and the Physicianabout 6 years ago
Becoming a Pharma Industry Leaderabout 6 years ago
Unlocking the Black Box of Pharma Pricing in Europeabout 6 years ago
The Risks and Rewards of Expedited Reviewabout 6 years ago
Using Service to Drive Commercial Valueabout 6 years ago
The Roots and Rise of Cell and Gene Therapyabout 6 years ago
Pharma Outsourcing: Keys to Productivity in 2020sNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5




